Mounjaro 2.5mg: What the Starting Dose Actually Means for You

Why the decision starts at 2.5mg, not higher

A question our prescribers hear most weeks is some version of: "If 2.5mg isn't doing much, why not skip straight to 5mg?" It's a fair instinct. The answer is that the gastrointestinal side effects of tirzepatide (nausea, loose stools, indigestion) are dose-related. Starting low gives your gut time to adapt before the medicine reaches the doses where it does most of its work on appetite and blood sugar. Rushing that process tends to produce more discomfort, not faster results.

The 2.5mg pen covers four weekly injections and is injected once a week into the abdomen, thigh, or upper arm. Sites should be rotated. After roughly four weeks, most people move up, though the prescriber sets that timing based on how the first pen went, not a fixed calendar. If side effects were significant, staying at 2.5mg a little longer is sometimes the right call. You can read more about the broader clinical profile on the Mounjaro treatment overview page.

What the 2.5mg period tells your prescriber, and you

The starter dose is, in part, a diagnostic window. How your body handles 2.5mg of tirzepatide gives the prescriber useful information: whether GI symptoms are manageable, whether injection-site reactions appear, whether there are any early signs of concerns that warrant a slower titration or a reassessment of suitability. None of that information is available without going through it.

Trial data from the SURMOUNT programme, published in the New England Journal of Medicine, showed that at the highest doses tirzepatide produced average body-weight reductions of around 20–21% over 72 weeks. Those results came from a full titration schedule, starting, as all participants did, at 2.5mg. The 2.5mg phase is not separate from the outcome; it is the foundation of it.

For people who have transferred from another provider and are already on a higher dose, the prescriber will review evidence of current treatment before continuing at that level. The same clinical logic applies: the starting point matters to everything that follows.

Tolerability, side effects, and what to watch for at this dose

Most people find the 2.5mg phase the easiest part of treatment. That said, some do experience nausea, mild stomach discomfort, or looser stools in the first week or two, and if you want a clearer picture of what to expect early on, our page on what Mounjaro day 2 typically feels like walks through the experience in detail. These effects tend to settle as the body adjusts. Fatigue and headache occasionally appear early on and usually pass.

The side effects worth taking seriously (at any dose, including 2.5mg) are severe or persistent stomach pain, particularly if it spreads toward the back. The MHRA highlighted acute pancreatitis as a known, if infrequent, risk across GLP-1 medicines in a Drug Safety Update issued in January 2026; anyone experiencing that symptom pattern should get medical help promptly rather than waiting to see if it passes. The NHS tirzepatide medicine page has a full list of side effects to be aware of.

Under-18s are not licensed to use Mounjaro. It is also not suitable during pregnancy, while breastfeeding, or for those actively trying to conceive, your prescriber will cover all contraindications during assessment. Women taking oral contraceptives should discuss whether an additional non-oral method is needed during the first four weeks of treatment, as tirzepatide can affect pill absorption.

The 2.5mg dose in the context of cost and access

Because 2.5mg is the starter dose, it is the first pen most private patients purchase. Private treatment pricing in the UK varies by dose and provider, and the 2.5mg pen is generally at the lower end of the per-pen range. Understanding what any quoted price does and does not include is worth the time, some providers charge separately for the consultation, prescription, and delivery. A fuller breakdown of how private Mounjaro pricing works is on the Mounjaro cost in the UK page.

On the NHS, access to tirzepatide follows a phased rollout tied to BMI thresholds and specific comorbidities. For those who do not meet the current NHS criteria or prefer not to wait, a private route through a regulated pharmacy requires a prescription following a proper clinical assessment, no shortcuts exist for a prescription-only medicine. If you are curious about what type of drug Mounjaro actually is and how it works at a pharmacological level, that page covers the mechanism in full, and our weight-loss treatment options page sets out what we offer and how to get started. When you are ready, speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered clinician, not a triage algorithm. Those moving on from the starter pen can find guidance on what changes with the Mounjaro 5mg dose, and anyone wanting to look further ahead can also explore what Mounjaro month 2 typically involves as titration progresses.